Hepatic glucokinase levels and activity are lower in patients with T2D, which could contribute to increased hepatic glucose production and decreased glycogen levels in the liver (Clore et al. 2000, Haeusler et al. 2015). The gene discussed is GCK; the disease is type 2 diabetes mellitus.